d3a0bc13eb7ddf3199bd2d3cfd6dea4e

VIDAS NT-PROBNP2

NT-PROBNP2 LIVES

BIOMERIEUX SA·II·Colombia INVIMA·Expires September 11, 2033

Device classification

Risk class / Clase de Riesgo: II
Product type (Spanish): REACTIVO DIAGNOSTICO
Product type (English): DIAGNOSTIC REAGENT

Registration information

Analysis ID: d3a0bc13eb7ddf3199bd2d3cfd6dea4e
Expire date: September 11, 2033

Authorized company / Fabricante

Name (Spanish): BIOMERIEUX SA
Name (English): BIOMERIEUX SA

Product use / Uso del Producto

Spanish

VIDAS NT-PROBNP2 (PBN2) ES UNA PRUEBA CUANTITATIVA AUTOMATIZADA PARA SU USO EN LOS EQUIPOS DE LA FAMILIA VIDAS_x000D_ QUE PERMITE LA DETECCIÓN DEL FRAGMENTO N TERMINAL DEL PÉPTIDO NATRIURÉTICO CEREBRAL EN SUERO HUMANO O PLASMA (HEPARINA_x000D_ DE LITIO O SODIO) POR TÉCNICA ELFA (ENZYME-LINKED FLUORESCENT ASSAY). EL ANÁLISIS VIDAS NT-PROBNP2 (PBN2) SE UTILIZA_x000D_ COMO AYUDA EN EL DIAGNÓSTICO DE SOSPECHA DE INSUFICIENCIA CARDÍACA

English

VIDAS NT-PROBNP2 (PBN2) IS AN AUTOMATED QUANTITATIVE TEST FOR USE ON COMPUTERS IN THE VIDAS_x000D_ ENABLING DETECTION OF THE N-TERMINAL FRAGMENT OF BRAIN NATRIURETIC PEPTIDE IN HUMAN SERUM OR PLASMA (HEPARINA_x000D_ LITHIUM OR SODIUM) BY ELFA (ENZYME-LINKED FLUORESCENT ASSAY) TECHNIQUE. THE NT-PROBNP2 LIVES (PBN2) ANALYSIS WAS UTILIZA_x000D_ AS AN AID IN THE DIAGNOSIS OF SUSPECTED HEART FAILURE

About this record

Access comprehensive regulatory information for VIDAS NT-PROBNP2 (NT-PROBNP2 LIVES) in the Colombia medical device market through Pure Global AI's free database. This II medical device is registered under INVIMA analysis ID d3a0bc13eb7ddf3199bd2d3cfd6dea4e and manufactured by BIOMERIEUX SA. The device was registered on September 11, 2033.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.